<DOC>
	<DOC>NCT00818597</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of an extracorporeal application of a bed-side bioreactor containing human donor granulocytes on the course and outcome of septic shock in humans.</brief_summary>
	<brief_title>Extracorporeal Immune Support System (EISS) for the Treatment of Septic Patients</brief_title>
	<detailed_description />
	<mesh_term>Shock, Septic</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<criteria>sepsis with at least one organ failure (severe sepsis) or septic shock Participation in another study within the last 30 days Earlier participation in this study Pregnancy Bleeding, clinically not controlled (needing more than 2 red blood celltransfusions per day) Hemodynamic shock for more than 12 hours (systolic BP &lt;90mmHg) despite adequate therapy HIV infection HCV infection, active</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>septic shock</keyword>
	<keyword>immunoparalysis</keyword>
	<keyword>extracorporeal</keyword>
	<keyword>granulocyte bioreactor</keyword>
	<keyword>plasmapheresis</keyword>
</DOC>